Pharmacogenetic testing for the guidance of psychiatric treatment: A multicenter retrospective analysis

CNS SpectrumsEspadaler J, et al. | April 26, 2016

The authors investigated the association between clinical outcome and the recommendations of a pharmacogenetic test (Neuropharmagen) in patients with a variety of psychiatric conditions whose previous treatment regimen had failed. Non–drug naïve patients whose treatment followed the recommendations of pharmacogenetic testing were more likely to improve their condition than patients whose treatment did not. These results are consistent with previous clinical research on depressed patients, and this study also suggests that this benefit can be extended to psychiatric conditions other than depression.

Read the full article on CNS Spectrums